Skip to main content
. Author manuscript; available in PMC: 2020 Sep 23.
Published in final edited form as: Ann Surg. 2018 Apr;267(4):692–699. doi: 10.1097/SLA.0000000000002164

Table 2.

Survival and readmission after the first bowel obstruction admission following diagnosis of stage IV ovarian or pancreatic cancer

Treatment at the first MBO admission
Medical Management % Surgery % VGT %
Survival outcomes n = 2,463 n = 871 n = 249

In-hospital mortality* 12.9 12.4 9.2
30-day mortality* 31.4 18.1 41.9
90-day mortality* 54.3 41.8 81.4
180-day mortality* 65.9 57.2 89.9
Survival (days)*, a 72 (23-312) 128 (42-483) 38 (23-69)

Readmission outcomesb n = 2,146 n = 763 n = 226

Readmission for MBO* None 67.4 75.0 85.0
One 20.6 18.1 10.6
Two or more 11.9 7.0 4.4
*

p < 0.05

a

Time from hospital admission date until date of death, reported as median (interquartile range)

b

Readmission for MBO is measured among patients who were discharged alive from their first MBO admission (N = 3,135)

Abbreviations: MBO, malignancy-associated bowel obstruction; VGT, venting gastrostomy tube